Skip to content

A randomized double-blind placebo-controlled study for effects of aged garlic extract on fatigue

A randomized double-blind placebo-controlled study for effects of aged garlic extract on fatigue - A study for effects of aged garlic extract on fatigue

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000017095
Enrollment
40
Registered
2015-04-10
Start date
2015-04-23
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

Test material: Aged garlic extract Duration: 4 weeks Dose: 5g/day Test material: Placebo Duration: 4 weeks Dose: 5g/day

Sponsors

Momoya Co., Ltd.
Lead Sponsor
Kagawa Nutrition University
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Healthy males and females aged 20 to less than 65 years old. 2) Subjects who are capable of understanding the study, and those who can give written informed consents.

Exclusion criteria

Exclusion criteria: 1) Subjects who are allergic to products related to the test material of this study. 2) Subjects who are addicted to alcohol or has an extremely irregular dietary habit. 3) Subjects who take drugs, quasi-drugs, dietary supplements, health foods or something other which possibly have effects on this study. 4) Patients with organic diseases which apparently induce fatigue. 5) Subjects who are pregnant or breastfeeding, or desires to get pregnant during the study period. 6) Subjects who are judged unsuitable for this study by principal investigator.

Design outcomes

Primary

MeasureTime frame
Fatigue sensation : Visual Analog Scale

Secondary

MeasureTime frame
POMS, arithmetic task

Countries

Japan

Contacts

Public ContactYuko Nagata

Momoya Co., Ltd. Research & Development Division

y.nagata@momoya.co.jp048-735-6311

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026